Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Period 1	STARTED	Gefapixant 600 mg>Placebo	12
Period 1	STARTED	Placebo>Gefapixant 600mg	12
Period 1	COMPLETED	Gefapixant 600 mg>Placebo	10
Period 1	COMPLETED	Placebo>Gefapixant 600mg	12
Period 1	NOT COMPLETED	Gefapixant 600 mg>Placebo	2
Period 1	NOT COMPLETED	Placebo>Gefapixant 600mg	0
Period 2	STARTED	Gefapixant 600 mg>Placebo	10
Period 2	STARTED	Placebo>Gefapixant 600mg	12
Period 2	COMPLETED	Gefapixant 600 mg>Placebo	10
Period 2	COMPLETED	Placebo>Gefapixant 600mg	8
Period 2	NOT COMPLETED	Gefapixant 600 mg>Placebo	0
Period 2	NOT COMPLETED	Placebo>Gefapixant 600mg	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01432730/flow